Dihydrosanguinarine
ISO
3606-45-9
98%
CUIRAN
20mg/Bottle
2024-08-01
Standard of traditional Chinese medicine reference,natural compounds,nature active compounds,pharmaceutical screening active compounds
-
Product Description
-
Seller Information
-
DescriptionCertificatesBasic Info
-
Product Name:
Dihydrosanguinarine
Other Name:[1,3]Benzodioxolo[5,6-c]-1,3-dioxolo[4,5-i]phenanthridine,13,14-dihydro-13-methyl-;Sanguinarine,13,14-dihydro-;Sanguinarine,dihydro-;13,14-Dihydro-13-methyl[1,3]benzodioxolo[5,6-c]-1,3-dioxolo[4,5-i]phenanthridine;13,14-Dihydrosanguinarine;Dihydrosanguinarine;Hydrosanguinarine;Dihydrosanquinarine
CAS No.:3606-45-9
Molecular Formula:C20H15NO4
InChIKeys:InChIKey=CIUHLXZTZWTVFL-UHFFFAOYSA-N
Molecular Weight:333.343
Exact Mass:333.34
UNII:3H1ZKG80F7
DSSTox ID:DTXSID00189627
Categories:
Characteristics-
PSA:
40.2
XLogP3:4.68
Density:1.4±0.1 g/cm3
Melting Point:190-191 °C
Boiling Point:566.9±29.0 °C at 760 mmHg
Flash Point:176.8±21.5 °C
Refractive Index:1.720
Hazard IdentificationClassification of the substance or mixture
no data available
GHS label elements, including precautionary statements
Pictogram(s) no data available Signal word no data available
Hazard statement(s) no data available
Precautionary statement(s) Prevention no data available
Response no data available
Storage no data available
Disposal no data available
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Standard of traditional Chinese medicine reference,natural compounds,nature active compounds,pharmaceutical screening active compounds
-
Location:
Room 301, 3rd Floor, R&D Bullding, Private Science and Technology Park, Checheng South Road, wuhan Economic and echnologicalDevelopment Zone, wuhan City, Hubei Province. PCR
-
Payment Terms:
100% TT in advance
-
Average lead Time:
15
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
11-50
-
Year of Establishment:
2023
-
Certifications:
ISO9001:2015
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product
